Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of RGB-10 vs Forsteo in healthy volunteers
NCT02223416Phase 1Completed
- Sponsor
- Gedeon Richter Plc
- Primary completion
- Jan 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Terossa in osteoporosis (2 arms), sponsored by Gedeon Richter Plc. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Status: completed.
02
Drugs
Terossa
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02223416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02223416.